Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company (KFSHI), posted on X:
“Targeted Therapies in PTCL.
T cell lymphoma.
Drugs like Brentuximab vedotin, Pralatrexate, and JAK inhibitors are transforming treatment!
Learn how PI3K, EZH, ITK, and HDAC inhibitors impact signaling pathways and improve outcomes. Precision matters in oncology!”
